ganedenbc30
Cell therapyexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
1
Earliest trial started Aug 1, 2010 (NCT01184456)
Timeline
2010s
- Jan 1, 2010
Earliest Phase 2 Sponsor(trial)
Indications
Approved for
Mechanism of action
- microbiotaTissue restoration
microbiota tissue restoration
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- ganedenbc30
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01337609 | Phase 4 | Jun 1, 2011 | Ganeden Biotech, Inc., Harvard University |
| NCT01184456 | Phase 2 | Aug 1, 2010 | AIDS Healthcare Foundation, Ganeden Biotech, Inc. |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Ganeden Biotech, Inc. | For profit | 2 | 0 | 2 | 2010 |
| AIDS Healthcare Foundation | Academic/Hospital | 1 | 1 | 1 | 2010 |
| Harvard University | Academic/Hospital | 1 | 1 | 1 | 2011 |
3 organizations
Page 1 / 1